1. Product Overview
2. Research Methodology
3. Impact of COVID-19
on Norfloxacin Market
4. Executive Summary
5. Manufacturing
Norfloxacin
5.1.
Raw Material
5.2.
Machinery
5.3.
Manufacturing Methods
5.4.
Contact Details of Machinery & Raw Material Suppliers
6. Pharmacodynamic
Overview of Norfloxacin
6.1.
Mechanism of Action
6.2.
Absorption
6.3.
Volume of Distribution
6.4.
Protein Binding
6.5.
Metabolism
6.6.
Route of Elimination
6.7.
Half-Life
6.8.
Clearance
6.9.
Toxicity
7. India Norfloxacin
Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value &
Volume
7.2.
Market Share & Forecast
7.2.1. By Product Type (Prescription
v/s OTC)
7.2.2. By Source (In-house
v/s Contract Manufacturing Organizations)
7.2.3. By Form (Tablet,
Capsule, Eye drops, Syrup, Ointment and Injection)
7.2.4. By Route of
Administration (Oral, Intravenous, Topical, Ophthalmic)
7.2.5. By Distribution
Channel (Online v/s Offline)
7.2.6. By Application
(Urinary tract Infections, gynecological infections, bladder infections,
inflammation of the prostate gland, gonorrhea and Others)
7.2.7. By End User (Adult
v/s Paediatric)
7.2.8. By Region (North,
East, South, West)
7.2.9. By Company
7.3.
Product Market Map
8.
Market Dynamics
8.1.
Drivers/Opportunities
8.2.
Challenges/Restraints
9.
Market Trends & Developments
10.
Policy & Regulatory Landscape
10.1.
Custom Duty & Taxes
10.2.
Government Subsidy & Benefits
10.3.
Relevant Policies & Regulations (GMP, USFDA, WHO
Certifications)
11.
Import & Export Analysis
12.
Pricing Analysis
13.
India Economic Profile
14.
Competitive Landscape
14.1.
Company Profiles
14.1.1. Alkem Laboratories
Ltd.
14.1.1.1. Company Brief
14.1.1.2. Production Plants
& Capacity (If Available)
14.1.1.3. Financials (If
Available)
14.1.1.4. Captive Consumption
Vs Merchant Sale
14.1.1.5. Current & Future
Plans
14.1.2. Aristo
Pharmaceuticals Ltd.
14.1.3. Hetero Healthcare
Ltd.
14.1.4. Taurus Laboratories
Pvt. Ltd.
14.1.5. Alembic Ltd.
14.1.6. Ranbaxy Laboratories
Ltd.
14.1.7. Cipla Ltd.
14.1.8. Dr. Reddy’s
Laboratories Ltd.
14.1.9. IPCA Laboratories
Ltd.
14.1.10.
Emcure Pharmaceuticals Ltd.
15.
Strategic Recommendations
16. About Us &
Disclaimer